Role of nitric oxide in the control of sodium excretion

News in Physiological Sciences

Volumn 11, Issue 2, 1996, Pages 62-67

  Salazar, F Javier ^a   Llinás, Maria T ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030535225     PISSN: 08861714     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiologyonline.1996.11.2.62     Document Type: Article

References (15)

1. Alberola, A., J. M. Pinilla, T. Quesada, J. C. Romero, and F. J. Salazar. Role of nitric oxide in mediating renal response to volume expansion. Hypertension Dallas 19: 780-784, 1991.
2. Chen, P. Y., and P. W. Sanders. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88: 1559-1567, 1992.
3. Lüscher, T. F., Y. Dohi, and M. Tschdi. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J. Cardiovasc. Pharmacol. 19, Suppl. 5: S34-S42, 1992.
4. Manning, R. D., Jr., and L. Hu. Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs. Hypertension Dallas 23: 619-625, 1994.
5. Mattson, D. L., R. D. Roman, and A. W. Cowley. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension Dallas 19: 766-769, 1992.
6. Moncada, S., and A. Higgs. The L-arginine-nitric-oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
7. Nakamura, T., A. M. Alberola, and J. P. Granger. Role of renal interstitial pressure as a mediator of sodium retention during blockade of nitric oxide. Hypertension Dallas 21: 956-960, 1993.
8. 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1470-R1476, 1994.
9. Romero, J. C., and F. G. Knox. Mechanisms underlying pressure-related natriuresis: the role of the renin-angiotensin and prostaglandins systems. Hypertension Dallas 11: 724-738, 1988.
10. Romero, J. C., V. Lahera, M. G. Salom, and M. L. Biondi. Role of endothelium-dependent relaxing factor nitric oxide on renal function. J. Am. Soc. Nephrol. 2: 1371-1387, 1992.
11. Salazar, F. J., A. Alberola, J. M. Pinilla, J. C. Romero, and T. Quesada. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension Dallas 22: 49-55, 1993.
12. Salazar, F. J., J. M. Pinilla, J. C. Romero, and T. Quesada. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension Dallas 20: 113-117, 1992.
13. Sigmon, D. H., and W. H. Beierwaltes. Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am. J. Physiol. 265 (Regulatory Intergative Comp. Physiol. 34): R1276-R1283, 1993.
14. Stoos, B. A., O. A. Carretero, R. D. Farhy, G. Scicli, and J. L. Garvin. Endothelium-derived relaxing factor inhibits transport and increases cGMP content in cultured mouse cortical collecting ducts. J. Clin. Invest. 89: 761-765, 1992.
15. Takenaka, T., K. D. Mitchell, and L. G. Navar. Contribution of angiotensin II to renal hemodynamic and excretory responses to nitric oxide synthesis inhibition in the rat. J. Am. Soc. Nephrol. 4: 1046-1053, 1993.